JP2021525745A5 - - Google Patents
Info
- Publication number
- JP2021525745A5 JP2021525745A5 JP2020566736A JP2020566736A JP2021525745A5 JP 2021525745 A5 JP2021525745 A5 JP 2021525745A5 JP 2020566736 A JP2020566736 A JP 2020566736A JP 2020566736 A JP2020566736 A JP 2020566736A JP 2021525745 A5 JP2021525745 A5 JP 2021525745A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrido
- methylamino
- indole
- carboxylic acid
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018088728 | 2018-05-28 | ||
| CNPCT/CN2018/088728 | 2018-05-28 | ||
| PCT/EP2019/063562 WO2019228940A1 (en) | 2018-05-28 | 2019-05-27 | Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525745A JP2021525745A (ja) | 2021-09-27 |
| JP2021525745A5 true JP2021525745A5 (https=) | 2022-06-01 |
| JP7296992B2 JP7296992B2 (ja) | 2023-06-23 |
Family
ID=66912773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566736A Active JP7296992B2 (ja) | 2018-05-28 | 2019-05-27 | 細菌感染症の処置および予防のための新規オキソキノリジン化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210238197A1 (https=) |
| EP (1) | EP3802549B1 (https=) |
| JP (1) | JP7296992B2 (https=) |
| CN (1) | CN112204037A (https=) |
| WO (1) | WO2019228940A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020064661A1 (en) * | 2018-09-26 | 2020-04-02 | F. Hoffmann-La Roche Ag | Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection |
| CN113166174A (zh) * | 2018-11-22 | 2021-07-23 | 豪夫迈·罗氏有限公司 | 用于治疗和预防细菌感染的游离氨基化合物 |
| EP3887370B1 (en) * | 2018-11-27 | 2023-01-18 | F. Hoffmann-La Roche AG | Tricyclic compounds for the treatment and prophylaxis of bacterial infection |
| WO2020109191A1 (en) * | 2018-11-27 | 2020-06-04 | F. Hoffmann-La Roche Ag | Aryl compounds for the treatment and prophylaxis of bacterial infection |
| WO2020127624A1 (en) * | 2018-12-20 | 2020-06-25 | F. Hoffmann-La Roche Ag | Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003012670A (ja) * | 2001-04-10 | 2003-01-15 | Sato Pharmaceutical Co Ltd | 抗菌活性を有する４−オキソキノリジン系化合物 |
| UY31676A1 (es) * | 2008-02-28 | 2009-09-30 | "derivados de 3-metil-imidiazo-[1,2-b]-piridazina" | |
| WO2012047487A1 (en) * | 2010-09-27 | 2012-04-12 | Evolva Sa | 2-pyridone antimicrobial compositions |
| EP2686320B1 (en) | 2011-03-15 | 2016-05-18 | Merck Sharp & Dohme Corp. | Tricyclic gyrase inhibitors |
| PL2931716T3 (pl) * | 2012-12-13 | 2017-04-28 | Novartis Ag | Pochodne pirydonu i ich zastosowanie w leczeniu gruźlicy |
| CN110475777B (zh) * | 2017-03-30 | 2022-04-15 | 豪夫迈·罗氏有限公司 | 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物 |
| WO2020064661A1 (en) * | 2018-09-26 | 2020-04-02 | F. Hoffmann-La Roche Ag | Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection |
-
2019
- 2019-05-27 JP JP2020566736A patent/JP7296992B2/ja active Active
- 2019-05-27 CN CN201980036229.1A patent/CN112204037A/zh active Pending
- 2019-05-27 WO PCT/EP2019/063562 patent/WO2019228940A1/en not_active Ceased
- 2019-05-27 EP EP19731155.8A patent/EP3802549B1/en active Active
-
2020
- 2020-11-25 US US17/105,087 patent/US20210238197A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525745A5 (https=) | ||
| JP2014525453A5 (https=) | ||
| CN103102344B (zh) | 氨基喹唑啉类衍生物及其盐和使用方法 | |
| CA2814998C (en) | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors | |
| KR20140097118A (ko) | 항균 화합물 및 이의 사용 방법 | |
| JP5995728B2 (ja) | カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 | |
| JP2025535045A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質の複素環阻害剤及びその使用 | |
| JP7296992B2 (ja) | 細菌感染症の処置および予防のための新規オキソキノリジン化合物 | |
| JP7344125B2 (ja) | 細菌感染の治療及び予防のための新規ピリド［２，３－ｂ］インドール化合物 | |
| JP2003026574A (ja) | 抗バクテリア剤 | |
| RU2014111813A (ru) | Антибактериальные соединения и способы их применения | |
| JP2014525452A (ja) | 抗菌化合物および使用方法 | |
| HRP20150555T1 (hr) | Derivati etinila kao pozitivni alosterijski modulatori za mglur5 | |
| AU2004272414B2 (en) | 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) quinolonecarboxylic acid derivative | |
| JP2024540008A5 (https=) | ||
| EP0947513B1 (en) | Tricyclic amine derivatives | |
| JPH06503089A (ja) | 抗菌剤としての７−〔３−（１，１−ジアルキルメチル−１−アミノ）−１−ピロリジニル〕−キノロンおよびナフチリドンの光学異性体 | |
| JP7443351B2 (ja) | 細菌感染症の治療及び予防のための、置換ピリドインドール | |
| JPH0395176A (ja) | スピロ化合物 | |
| WO2016039937A1 (en) | Bicyclic and tricyclic substituted 2-pyridinone antibacterial compounds | |
| JPWO1998054169A1 (ja) | 置換シクロブチルアミン誘導体 | |
| Petersen | Quinolone antibiotics: the development of moxifloxacin | |
| CN113166145A (zh) | 用于治疗和预防细菌感染的三环化合物 | |
| JP4132155B2 (ja) | 三環性アミン誘導体 | |
| Limberakis | Quinolone Antibiotics: Levofloxacin (Levaquin®), Moxifloxacin (Avelox®), Gemifloxacin (Factive®), and Garenoxacin (T-3811) |